SMTL ID : 7e3k.1

Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-mer

Ligands

22 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)

NAG.1: 2 residues within 4Å: Chain A: Y.28, N.61 Ligand excluded by PLIP NAG.2: 2 residues within 4Å: Chain A: N.122, T.124 Ligand excluded by PLIP NAG.3: 1 residues within 4Å: Chain A: N.165 Ligand excluded by PLIP NAG.4: 2 residues within 4Å: Chain A: D.198, N.234 Ligand excluded by PLIP NAG.5: 3 residues within 4Å: Chain A: N.280, E.281, N.282 Ligand excluded by PLIP NAG.6: 1 residues within 4Å: Chain A: N.603 Ligand excluded by PLIP NAG.7: 2 residues within 4Å: Chain A: N.616, T.618 Ligand excluded by PLIP NAG.8: 2 residues within 4Å: Chain A: N.709, G.1131 Ligand excluded by PLIP NAG.9: 2 residues within 4Å: Chain B: Y.28, N.61 Ligand excluded by PLIP NAG.10: 1 residues within 4Å: Chain B: N.165 Ligand excluded by PLIP NAG.11: 2 residues within 4Å: Chain B: G.232, N.234 Ligand excluded by PLIP NAG.12: 2 residues within 4Å: Chain B: E.281, N.282 Ligand excluded by PLIP NAG.13: 1 residues within 4Å: Chain B: N.603 Ligand excluded by PLIP NAG.14: 2 residues within 4Å: Chain B: N.709, G.1131 Ligand excluded by PLIP NAG.15: 1 residues within 4Å: Chain C: N.61 Ligand excluded by PLIP NAG.16: 1 residues within 4Å: Chain C: N.122 Ligand excluded by PLIP NAG.17: 1 residues within 4Å: Chain C: N.165 Ligand excluded by PLIP NAG.18: 1 residues within 4Å: Chain C: N.234 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain C: N.280, E.281, N.282 Ligand excluded by PLIP NAG.20: 1 residues within 4Å: Chain C: N.603 Ligand excluded by PLIP NAG.21: 2 residues within 4Å: Chain C: N.616, T.618 Ligand excluded by PLIP NAG.22: 2 residues within 4Å: Chain C: N.709, G.1131 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, T. et al., Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants. Nat Commun (2021)

Release Date

2021-09-15

Peptides

Spike glycoprotein: ABC
13G9 heavy chain: DFH
13G9 light chain: EGI

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

F
F

H
H

E
E

G
G

I
L

Spike glycoprotein

13G9 heavy chain

13G9 light chain

Related Entries With Identical Sequence